Alivus Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alivus Life Sciences Limited has informed exchanges about a Board Meeting scheduled for May 14, 2026. The meeting will consider and approve the Audited Financial Results for Q4 and the year ended March 31, 2026. The Board will also consider recommending dividend on equity shares for FY 2025-26. As per SEBI regulations, the company has closed the Trading Window from April 1, 2026 to May 16, 2026, prohibiting designated persons from trading in company shares until after the results are announced.
The trading window closure is standard practice to prevent insider trading ahead of material announcements. The May 14 meeting could trigger positive movement if dividend is declared or results beat expectations.